LCOR expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.90520044185405E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.61589996728173E-09 |
Normal-vs-Stage2 |
1.46109999987765E-07 |
Normal-vs-Stage3 |
6.39066577434733E-12 |
Normal-vs-Stage4 |
2.02590166864525E-11 |
Stage1-vs-Stage2 |
7.839800E-01 |
Stage1-vs-Stage3 |
1.797870E-03 |
Stage1-vs-Stage4 |
8.824300E-03 |
Stage2-vs-Stage3 |
1.026620E-01 |
Stage2-vs-Stage4 |
1.025200E-01 |
Stage3-vs-Stage4 |
8.671200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.44870013155207E-10 |
Normal-vs-AfricanAmerican |
6.2588045857126E-11 |
Normal-vs-Asian |
3.042600E-01 |
Caucasian-vs-AfricanAmerican |
1.290200E-01 |
Caucasian-vs-Asian |
3.142000E-02 |
AfricanAmerican-vs-Asian |
8.717800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.56800017414582E-10 |
Normal-vs-Female |
7.36870009454549E-10 |
Male-vs-Female |
5.893000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.40839999995812E-06 |
Normal-vs-Age(41-60Yrs) |
3.50850004604553E-09 |
Normal-vs-Age(61-80Yrs) |
5.28249666231773E-11 |
Normal-vs-Age(81-100Yrs) |
5.1788995314439E-10 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.780000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.094600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.217000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.424200E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.877900E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.981800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.084300E-03 |
Normal-vs-Grade 2 |
5.17900000662763E-09 |
Normal-vs-Grade 3 |
1.77569958736967E-10 |
Normal-vs-Grade 4 |
2.01361149976265E-12 |
Grade 1-vs-Grade 2 |
4.115000E-01 |
Grade 1-vs-Grade 3 |
1.612980E-01 |
Grade 1-vs-Grade 4 |
6.156900E-03 |
Grade 2-vs-Grade 3 |
1.292970E-01 |
Grade 2-vs-Grade 4 |
1.621920E-04 |
Grade 3-vs-Grade 4 |
1.699960E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.98210000027055E-08 |
Normal-vs-ccB subtype |
8.68319971480958E-10 |
ccA subtype-vs-ccB subtype |
1.070380E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.23510002225657E-09 |
Normal-vs-N1 |
2.243000E-03 |
N0-vs-N1 |
9.266800E-01 |
|
|